From 1979 to 1996, 58 patients (mean age, 39.4 years) were treated for bacteremia due to Campylobacter species at the Hospitals Vall d'Hebron in Barcelona, Spain. Bacteremia was considered to be hospital acquired in 30% of these patients. Almost all the patients (93%) had underlying conditions; liver cirrhosis was the most frequent (34% of patients), and neoplasia, immunosuppressive therapy, and human immunodeficiency virus disease were also common. Of the 58 Campylobacter strains isolated, 81% were C. jejuni, 10% were Campylobacter species, 7% were C. fetus, and one (2%) was C. coli. Resistance rates were: cephalothin, 82%; co-trimoxazole, 79%; quinolones, 54%; ampicillin, 20%; amoxicillin/clavulanate, 4%; erythromycin, 7%; gentamicin, 0; and tetracyclines, 0. Even though the majority of patients were immunocompromised, mortality was low (10.5%), and only one patient relapsed. Because of the high level of resistance to the quinolones in Campylobacter species, these drugs should not be used as empirical treatment, at least in Spain. Although the macrolides remain the antibiotics of choice, amoxicillin/clavulanate may be an effective alternative therapy.
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Campylobacter species (especially C. jejuni) have become 1979 and 31 December 1996 at the Hospitals Vall d'Hebron (Barcelona, Spain). This university-affiliated public health inan increasingly recognized cause of gastroenteritis in children and adults. Bacteremia caused by these microorganisms is unstitution with a 1,300-bed capacity (1,600 beds before 1991) has active programs in solid-organ and bone marrow transcommon [1 -4] , and most reports of bacteremia due to Campylobacter species describe only a small number of cases [5 -8] .
plantation. For the records review, we placed special emphasis on time of the year when bacteremia occurred, whether it was The significant increase in the number of compromised patients in Spanish hospitals (e.g., transplant recipients, HIV-infected community acquired or nosocomial, the presence of underlying conditions, the clinical findings and associated complications, patients, and those receiving immunosuppressive therapy) may be responsible for the increase in the prevalence of campylotherapy, and outcome. Nosocomial bacteremia was defined according to the 1988 bacter bacteremia. The clinical findings and the outcome for patients with campylobacter bacteremia have not been extenCenters for Disease Control (CDC) definition for nosocomial infections [11] . Diagnoses of AIDS were made on the basis of sively studied, especially in this group of compromised patients.
the 1987 CDC surveillance criteria for AIDS [12] . Antibiotic therapy was considered inappropriate if the isolate proved to Erythromycin is the antimicrobial agent most frequently used to treat these infections, and the quinolones have been recombe resistant to the empirically chosen drugs. The death of a patient was considered to be related to bacteremia only if the mended as alternative therapy. However, several reports have shown increasing resistance of C. jejuni to quinolones, a fact bacteremic episode was shown to be the direct cause of death. Under other circumstances, death was considered to be unrethat deserves concern [1, 4, 9, 10] .
The purpose of our study was to review the clinical features, lated to bacteremia. Over the period of the study, three different blood culturing underlying conditions, antimicrobial susceptibility patterns, and outcome for 58 patients with campylobacter bacteremia. methods were in use at our hospital. During the first period (1979 -1985) , conventional blood cultures were performed with use of Castañeda and anaerobic medium. Both bottles Patients and Methods were examined daily the first week and once on the 14th day, We reviewed the medical records of all patients who had before patients were discharged. Blind subcultures were done bacteremia due to Campylobacter species between 1 January on the second and seventh day in aerobic and anaerobic atmospheres. During the second period (1986 -1995) Child B or C, was the most frequent (34% of patients), and Campylobacter species was suspected (i.e., the isolates were curved or spiral gram-negative rods), subculture was done on neoplasia and immunosuppression due to chemotherapy were also common. nonselective blood agar plates incubated under microaerophilic (10% CO 2 , 5% O 2 , and 85% N 2 ) conditions at 37ЊC and 43ЊC
Seven cases occurred in HIV-infected patients (two of these patients had liver cirrhosis as well). Our first case showing the for 3 days.
Stool samples were plated on brain-heart infusion agar with association between HIV infection and campylobacter bacteremia was identified in 1986, and since then we have diagnosed 5% hemolyzed blood and vancomycin, cefoxitin, colistin, and amphotericin B. Plates were incubated at 37ЊC in a microaero-41 cases of campylobacter bacteremia. Thus, the overall incidence of this association is 17% (7 of 41 cases) in our series. philic atmosphere for 3 days. The cultures were examined daily.
Campylobacter strains were identified by means of the folFrom 1981 to 1996, Ç1,200 cases of AIDS were diagnosed at our hospital; therefore, the incidence of campylobacter bacterlowing tests: dark-field microscopy for motility and morphology, gram staining and oxidase and catalase production, hydroemia in this group of patients was Ç0.6%. AIDS had previously been diagnosed for all seven of our patients with campylobacter lysis of sodium hippurate, H 2 S production on triple sugar iron and in the presence of 1% cysteine hydrochloride (lead acetate bacteremia and HIV disease. All cases were classified as IV A or C, according to the 1987 CDC classification for HIVstrip method with brain-heart broth as base), growth on brainheart blood agar plates incubated at 25ЊC and 42ЊC, and suscepinfected patients. Six patients were receiving trimethoprimsulfamethoxazole prophylaxis for Pneumocystis carinii pneutibility to nalidixic acid (130-mg disk) and cephalothin (66-mg disk). The microorganism was considered to be susceptible to monia. All the isolates from these patients were resistant to co-trimoxazole. None of these patients was neutropenic, but nalidixic acid and cephalothin when the diameter of the zone of inhibition was §25 mm and §23 mm, respectively. all had low CD4 lymphocyte counts (mean count, 19/mm 3 ; range, 1 -36/mm 3 ). The antibiotic susceptibility of Campylobacter strains was determined by the Kirby-Bauer disk diffusion method [13] on Three of the patients were pregnant, and two of them had spontaneous miscarriages during the episode of bacteremia. Mueller-Hinton agar plates with 5% horse blood with use of Rosco disks (Neo-Sensitab; Rosco Diagnostica, Tåstrup, Denmark) [14] .
All 16 patients with hospital-associated campylobacter bacteremia had underlying conditions (immunosuppression related Susceptibility to erythromycin (78-mg disk, zone of inhibition §26 mm) was determined over the entire study period. In addito corticosteroid therapy [8] , chemotherapy [4] , or transplantation [4] ; liver cirrhosis [3] ; systemic lupus erythematosus [2] ; tion, since 1989, the susceptibility of Campylobacter species to the following agents was determined: ciprofloxacin (10-mg disk, chronic renal failure [2] ; HIV infection [1] ; leukemia [1] ; lymphoma [1] ; and solid-organ neoplasia [1] ). zone of inhibition §20 mm), norfloxacin (10-mg disk, zone of inhibition §16 mm), ampicillin (33-mg disk, zone of inhibition Microorganisms. The median time until detection of positive blood cultures was 3 days (range, 2-7 days). Of the 58 Campylo- §20 mm), doxycycline (80-mg disk, zone of inhibition §20 mm), gentamicin (40-mg disk, zone of inhibition §23 mm), trimethobacter species isolated, 47 (81%) were C. jejuni, four (7%) were C. fetus, six (10%) were Campylobacter species, and one (2%) prim-sulfamethoxazole (co-trimoxazole; 5.2/240-mg disk, zone of inhibition §28 mm), and amoxicillin/clavulanate (30/15-mg disk, was C. coli. Stool cultures were performed for 37 patients, and 15 (40%) were positive; C. jejuni was isolated in all cases. All zone of inhibition §20 mm).
four patients with C. fetus bacteremia had negative stool cultures.
In one case C. jejuni was also isolated from the peritoneal fluid, Results and in another, C. fetus was also recovered from a gluteal abscess. Table 2 shows antimicrobial resistance rates among the 58 From 1979 to 1996, campylobacter bacteremia was diagnosed in 58 patients; half of these cases were diagnosed in the isolates of Campylobacter species from our patients. Since / 9c40$$de08 11-04-97 17:49:52 cidas UC: CID 
* Some patients had more than one underlying condition. † Refers only to antineoplastic agents. ‡ Leukemia (3 patients), lymphoma (3), and solid-organ neoplasms (2). § Liver (3), kidney (1), bone marrow (1). Percentage refers to 54 patients for whom data were available.
1991, we have witnessed a striking increase in the percentage manifestation (91% of patients). Only one-third (18 of 54) of the patients had diarrhea, and stool cultures were positive for of strains resistant to the quinolones (81%, 13 of 16 isolates); the percentage for nalidixic acid was 88% (14 of 16 isolates).
12 (66%) of them. Stool cultures were performed for 19 of the 36 patients without diarrhea, and three (16%) were positive. Erythromycin resistance during that period was 11% (three of 27 isolates). Twenty percent of the isolates were resitant to Four patients had cellulitis; one had arthritis of the knee and a negative articular fluid culture, one had meningoencephalitis, ampicillin, but only 4% were resistant to amoxycillin/clavulanate.
one developed lower-leg thrombophlebitis (due to C. fetus), and one had pancreatitis, although she also had received cortiThere were no relevant differences in antibiotic susceptibility between strains isolated from hospital-associated and commucosteroid therapy. One alcoholic woman with a previous contusion that caused a large gluteal hematoma was admitted to the nity-acquired campylobacter bacteremia.
Clinical features. The clinical characteristics of the patients hospital for treatment of hepatic encephalopathy. Two weeks later she developed fever, and the gluteal contusion became are shown in table 3. Fever was the most common clinical painful. Cultures of blood and gluteal exudate yielded C. fetus. 10 -14 days. Erythromycin was the antibiotic most often used. It is of interest that the results were good for three patients She recovered after drainage was performed and a 3-week course of erythromycin therapy was administered. It is notewho received only amoxicillin/clavulanate. Only one patient, an 8-month-old child with advanced HIV disease, relapsed. worthy that two patients had pulmonary involvement: one had right lower-lobe pneumonia, and the other had bilateral pulmoDespite adequate and prolonged courses of antimicrobial therapy (3 weeks each), she had three relapses and finally died nary infiltrates and no abnormal findings on echocardiographic and bronchoalveolar lavage studies. In both cases the pulmowith fever, diarrhea, and C. jejuni bacteremia. nary lesions resolved with erythromycin therapy alone; serological studies for Mycoplasma pneumoniae, Legionella pneuDiscussion mophila, and Chlamydia psittaci were negative. Only one of the 58 patients developed septic shock and disseminated intraCampylobacter bacteremia is an uncommon disease [2] . As reported in other studies, the incidence in our series reached vascular coagulation. None of the patients developed GuillainBarré syndrome (GBS) over a 6-month follow-up period.
a peak in the summer and early fall months [1, 4, 15] and predominantly affected males (two-thirds of the cases) [1, 2, Almost all of the 16 patients (87.5%) with hospital-associated campylobacter bacteremia had fever, six (37%) had diar -4] . In contrast to other investigators [2, 15] , we did not find a high incidence of this disease among patients ú65 years old; rhea, and one each had extraintestinal manifestations (cellulitis and pancreatitis).
however, there was a considerable incidence among children. Campylobacter bacteremia usually occurs in patients with Outcome. The overall mortality was 10.5% (6 of 57 patients). The mortality among patients with hospital-associated underlying conditions such as liver cirrhosis, malignancy, diabetes mellitus, HIV disease, and/or therapy-induced immunocampylobacter bacteremia was 12.5% (two of 16 patients). Death was considered to be related to campylobacter bactersuppression. This association is high in the case of C. fetus bacteremia [1, 5, 8] ; however, in the case of C. jejuni bacteremia for three of the six patients who died (the empirical antibiotic therapy was not appropriate in two cases). Death was emia, a relationship as strong as we observed (94% of our 47 cases) has not been previously reported [1, 2, 4] . due to hepatic failure in the other three (two had liver cirrhosis, and one had a liver transplant and chronic rejection). There
In one-third of our cases, bacteremia was considered to be hospital acquired. Other authors have not found such a high were no deaths among patients with no underlying diseases or among the pregnant women.
incidence of this association [1 -4] . Although we do not know the prevalence of carriage of this microorganism in Spain, The outcome was favorable for one-fifth of the survivors (11 of 52), although they had not received antimicrobial therapy we believe that the majority of our patients were exposed to Campylobacter species in the hospital, since the symptoms or had received inappropriate antibiotic treatment (two cases). These patients had already been discharged before culture re-(fever and/or diarrhea) appeared several days after admission, and bacteremia was detected a mean of 19 days (range, 4 -52 sults were available. Thirty-nine patients recovered after receiving antibiotic treatment. The duration of therapy lasted from 1 days) after admission. Increased immunosuppression during hospitalization may also have played a role in some cases. to 3 weeks, and the majority of these patients were treated for / 9c40$$de08
11-04-97 17:49:52 cidas UC: CID Although there are no data on whether immunosuppression in a healthy or compromised host following acute campylobacter enteritis. The bacteremia usually resolves spontaneously, increases susceptibility to infection with a smaller inocula of Campylobacter species, immunosuppressive therapy increases and no specific treatment is required. This clinical pattern is common among patients with C. jejuni bacteremia (38% of our the risk of other foodborne diseases such as listeriosis [16] , and hospitalized patients with underlying conditions are more patients had diarrhea) and exceptional among those with C. fetus infections (none of our patients had gastroenteritis). immunosuppressed than outpatients [16] .
Since most of our patients had underlying conditions Second, sustained bacteremia may occur in patients infected with strains that, in general, are relatively or absolutely serum and/or were receiving immunosuppressive therapy, this fact may partially explain the high incidence of nosocomial cases resistant. This situation is more common with C. fetus [1, 4, 34] . The outcome is favorable when antimicrobial therapy is in our study. Because of the possibility that highly immunosuppressed persons may be more susceptible to lower inocula of administered. Third, sustained bacteremia may occur in a compromised host; as was shown in our study, many such patients microorganisms than the general population, it may be also advisable that such patients avoid undercooked foods, soft do not have acute enteritis. In some of these cases, bacteremia is recurrent, and antimicrobial therapy may need to be procheeses, and any other products prepared from unpasteurized milk.
longed [1, 35] . In our experience, recurrent bacteremia was unusual, and Sporadic cases of bacteremia due to Campylobacter species have been described in patients with AIDS [17 -19] . However, although many of our patients had an underlying condition, we observed only one relapse in an HIV-infected patient. Characin cumulative series of AIDS patients with bacteremia, only one case due to Campylobacter species was reported among terization of these strains in terms of pathogenicity (serum resistance) and virulence, which was not available in our study, 291 patients with bacteremia [20 -23] . The relatively high rate of campylobacter bacteremia we found is probably related to could have provided further information on the different clinical patterns of campylobacter bacteremia. the high incidence of enteric infections due to this microorganism in our country, both in patients with and in patients without A variety of extraintestinal manifestations of campylobacter infection, such as cholecystitis, endocarditis, peritonitis, septic HIV infection [9, 10, 24, 25] .
It is interesting to note that all the HIV-infected patients in arthritis, meningitis, lung abscess, empyema, vertebral osteomyelitis, cellulitis, and septic thrombophlebitis, have been docour study had advanced HIV disease. Sorvillo et al. [26] suggested that infections due to Campylobacter species in patients umented [1, 3 -6, 35 -37] , particularly in patients with C. fetus infections. Cellulitis is a relatively common manifestation (7% with AIDS could be a marker for significant deterioration in immune status and that the presence of bacteremia implies of cases in our study); however, cutaneous abscess, as observed in one of our patients (previously published case report), is limited survival. The increasing use of macrolides to treat infections due to Cryptosporidium species and for prophylaxis and exceptional [38] . Pleural empyema and lung abscess due to Campylobacter species are rare but well-recognized infections treatment of Mycobacterium avium complex infections in patients with AIDS may decrease the incidence of campylobacter [1, 35] . It has not as yet been clearly established that Campylobacter infections in the future. It has recently been suggested that rifabutin, a drug active against Campylobacter species in vitro species are etiologic agents of pneumonia. However, in one series of extraintestinal manifestations of campylobacter infecand used for prophylaxis and treatment of mycobacterial diseases in patients with AIDS, seems to protect these patients tion [35] , two cases of pneumonia were reported. Two of our patients had pneumonia that resolved with erythromycin therfrom campylobacter infections as well [27] .
Although C. fetus has been considered to be more likely to apy alone. No causal microorganisms were demonstrated (even when bronchoalveolar lavage was performed in one case). The cause bacteremia than C. jejuni [1, 3, 6, 8] , C. jejuni has been the predominant species in several studies of campylobacter fact that specific cultures for Campylobacter species are not routinely done with respiratory samples makes us believe that infections [2, 5, 28, 29] . In our study, 90% of the isolates identified were C. jejuni, a microorganism that is highly prevaCampylobacter was the most probable etiologic agent. C. jejuni is implicated as a trigger of GBS in 20% -40% of lent in our country. In a review of four articles on acute gastroenteritis in Spain, the incidence of campylobacter infection cases [1, 4, 38, 39] . Antibody cross-reactivity between bacterial cell-surface structures (including the C. jejuni 0:19 lipopolysacranged from 11% to 33% [30 -33] . In our experience with gastroenteritis, Campylobacter species were the second most charide) and nervous system glycolipids or myelin proteins may explain the pathogenesis of this disease. It is not surprising common agents isolated (27.6% of 4,407 isolates identified during a 9-year period) after Salmonella species (unpublished that none of our patients developed GBS, since the estimated incidence of this complication is lower than one case per 2,000 results). Of all the campylobacters isolated in stool cultures, we found that 97% were C. jejuni.
cases of C. jejuni infection [40] . It could also be speculated that since GBS might be an immunopathological reaction to Bacteremia due to Campylobacter species can manifest in three clinical patterns [1] . First, transient bacteremia may occur Campylobacter, compromised patients might be at lower risk / 9c40$$de08 11-04-97 17:49:52 cidas UC: CID for GBS because of the impaired immunological response. patients had advanced HIV disease). Even though the majority of patients were immunocompromised, the mortality was low. Since certain serotypes are associated more frequently with GBS, serotyping could have provided some additional informaBecause of the high rate of resistance of Campylobacter species to the quinolones, these drugs should not be used as empirical tion about the absence of cases of GBS in our study.
Although most of our patients had an underlying conditreatment, at least in Spain. Although the macrolides remain the antibiotics of choice, amoxicillin/clavulanate has shown tion, the mortality directly related to campylobacter infections was low (5%) and was similar to the mortality (2.5%) potential as an alternative therapy. reported in a recent paper by Skirrow et al. [2] . These data contrast with those from previous studies in which the mor-
